Sage Journals: Discover world-class research

Abstract

Objective:

We describe development and preliminary testing of Vanderbilt Head and Neck Symptom Survey—Recurrent/Metastatic (VHNSS-RM) to assess residual symptoms, tumor-related symptoms, and side effects from therapy.

Methods:

Items were identified through patient and provider interviews. Card sort selected high-yield and high-impact items. The VHNSS-RM was administered to 50 patients with recurrent/metastatic head and neck cancer (RMHNC).

Results:

The VHNSS-RM includes 12 unique symptoms (diet change, tongue movement affecting speech/swallowing, face/neck swelling, neck/jaw cramping, bad breath, drooling, wound drainage/pain/odor, nasal congestion/drainage, eyes watering, face/tongue/ear/scalp numbness, headaches, and confusion) and 7 unique psychosocial issues (burden to family/friends, lost independence, fear, embarrassment, mood swings, stress, and boredom).

Conclusions:

The VHNSS-RM contains 35 physical and 12 psychosocial issues. The VHNSS-RM is feasible and not overly burdensome. Nineteen unique items may improve palliation to patients with RMHNC.

Keywords

recurrent head and neck cancer metastatic head and neck cancer patient-reported outcomes symptom burden toxicities unique symptoms

Get full access to this article

View all access options for this article.

References

Murphy

. Advances in quality of life and symptom management for head and neck cancer patients. Curr Opin Oncol. 2009;21 (3):242–247.

Kolnick

Deng

Epstein

. Associations of oral health items of the Vanderbilt Head and Neck Symptom Survey with a dental health assessment. Oral Oncol. 2014;50 (2):135–140.

Murphy

Gilbert

Cmelak

Ridner

. Symptom control issues and supportive care of patients with head and neck cancers. Clin Adv Hematol Oncol. 2007;5 (10):807–822.

Murphy

Gilbert

Ridner

. Systemic and global toxicities of head and neck treatment. Expert Rev Anticancer Ther. 2007;7 (7):1043–1053.

Bentzen

Trotti

. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol. 2007;25 (26):4096–4103.

Cooperstein

Gilbert

Epstein

. Vanderbilt head and neck symptom survey version 2.0: report of the development and initial testing of a subscale for assessment of oral health. Head Neck. 2011;34 (6):797–804.

List

D’Antonio

Cella

. The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale. A study of utility and validity. Cancer. 1996;77 (11):2294–2301.

Rosenthal

Mendoza

Chambers

. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module. Head Neck. 2007;29 (10):923–931.

Rogers

Gwanne

Lowe

Humphris

Yueh

Weymuller

Jr . The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck. 2002;24 (6):521–529.

10.

Osthus

Aarstad

Olofsson

Aarstad

. Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2013;139 (1):14–20.

11.

Harris

Taylor

Thielke

Payne

Gonzalez

Conde

. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42 (2):377–381.

12.

Temel

Greer

Muzikansky

. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363 (8):733–742.

Preliminary Testing of a Patient-Reported Outcome Measure for Recurrent or Metastatic Head and Neck Cancer

Abstract

Objective:

Methods:

Results:

Conclusions:

Keywords

Get full access to this article

References